| Literature DB >> 35308508 |
Solomon Owusu Sekyere1,2, Ivana Škrnjug-Yudov1,2, Alexander Pinz1, Heidi Meyer1,2,3, Christoph Conrad1,2,3.
Abstract
Background: Development of safe and efficacious medicines in many sub-Sahara African countries remains hampered due to fragmented health research infrastructure and ineffective regulatory oversight. To boost the latter in the area of Clinical Trials (CT) Oversight (CTO), many international programs and Regional Centers for Regulatory Excellence (RCORE) initiatives offer various trainings to help strengthen human resource capacity. Here, we aimed at evaluating the training outcomes (at home-institution level) of sponsored fellows for one of such capacity strengthening interventions; a measure that is less often reported and thus remains poorly understood. Method: The Global Health Protection Programme's VaccTrain project sponsored nine regulatory staff from eight National Medicines Regulatory Authorities (NMRAs) in sub-Saharan Africa for the RCORE CT Training Fellowship by FDA Ghana in a particular year. Using a systematized evaluation framework based on the theory of change, we assessed the individual- and NMRA-level achievement of pre-defined training outcomes. For this purpose, data was collected at pre-training and at short- and long-term evaluation time-points using a survey instrument.Entities:
Keywords: RCORE training fellowship; capacity building; clinical trials; clinical trials oversight; medicines regulation; regulatory systems strengthening; staff training; training outcomes
Year: 2022 PMID: 35308508 PMCID: PMC8924119 DOI: 10.3389/fmed.2022.772605
Source DB: PubMed Journal: Front Med (Lausanne) ISSN: 2296-858X
Overview of the training's evaluation framework-matrix in achieving its set outcomes.
|
|
|
|
|---|---|---|
| Input | All resources (e.g., financial, human, material, etc.) that are used to implement a specific capacity development intervention. | • Financial support/ sponsorship (i.e., financially offsetting the cost of participation in the CT RCORE fellowship) |
|
| ||
| Output | The direct results of programme or project input activities (e.g., services and products) that are usually relevant to the target group's achievement of outcomes. | • Successful completion of the training by the sponsored fellows according to a curriculum |
|
| ||
| Outcome | The actual or intended changes in performance or behavior measured in the form of deliverables at the target-group level within a defined period of time | Short-term: |
|
| ||
| Impact | The long-term, higher level effect a project is designed to achieve, usually at the societal level | • Improved access to medicines and novel treatments |
A typical case description across the different components of the logic model.
Sponsored participants and their respective roles in home institutions.
|
|
|
|---|---|
| A | Clinical trials |
| B | Clinical trials and pharmacovigilance |
| C | Clinical trials and pharmacovigilance |
| D | Clinical trials |
| E | Medicines registration |
| F | Clinical trials and pharmacovigilance |
| G | Testing laboratory |
| H | Clinical trials and pharmacovigilance |
| I | Not available |
Figure 1Pre-training expectations of fellows: Data on pre-training expectations were collected one week prior to start of the training fellowship using a questionnaire. (A) An individual-based representation of fellows' expectations which were either related to operational Clinical Trials Oversight activities (i.e., CTO-related) or generic and not related to operational Clinical Trials Oversight activities (i.e., non-CTO-related). (B) An individual-based representation of supervisors' expectations that were either CTO-related or generic (i.e., non-CTO-related).
Figure 2Evaluation of short-term post-training outcomes of the individual fellows: Information was sought either directly from the trained fellows or from their supervisors on issues of achieved training outcomes as well as knowledge transfer 3–4 months after the training. (A) A graphical illustration of individual responses from all sponsored fellows showing the kind of reported deliverables (outcomes). (B) Individual responses from respective supervisors on the status of post-training outcomes that were expected from the fellows. (C) Individual responses from respective supervisors on the status of knowledge transfer or sharing conducted as per NMRA guidelines.
Figure 3Assessment of training success and factors that influenced achievement of training outcomes at short-term: The effectiveness of the training was mapped to parameters that facilitate implementation success in fellows' NMRAs. (A) Percentage completion of short-term project-defined outcomes based on indicators related to implemented CTO-related deliverables and conducted internal seminar for knowledge sharing. (B) Number of trial participants involved in CTs at varying stages of recruitment (i.e., recruiting, active—not recruiting, or completed) used as a proxy indicator of CT vibrancy in the respective NMRAs. Data was derived from clinicaltrials.gov on 08.02.2020 (dd.mm.yyyy). (C) Availability, accessibility, and content of CT guidelines that govern the conduct of CTs in the jurisdictions of the respective NMRAs of sponsored fellows.
Figure 4Long-term follow-up evaluation of fellows' outcomes and improvements of CTO activity at the NMRA level: Information was sought from fellows using an electronic survey on issues of individual-level achieved training outcomes and organizational-level improvements in CTO 15 months after the training. (A) Individual responses from all sponsored fellows showing the kind of outcomes (CTO-related, non-CTO-related, others) reported cumulatively (i.e., at short- and long-term evaluation time-points). (B) A comparative assessment of individual fellow responses (reported outcomes) at the short- and long-term evaluation time-points. (C) Individual responses from fellows on the status of knowledge sharing conducted as per NMRA guidelines. (D) Individual fellow responses on NMRA-level improvements in routine CTO activities and related procedures as well as CTO procedures in health emergencies.
Figure 5Assessment of training success and factors that influenced achievement of training outcomes at long-term. The effectiveness of the training was mapped to parameters that facilitate implementation success in fellows' NMRAs. (A) Percentage completion of long-term project-defined outcomes based on indicators related to implemented CTO-related deliverables and conducted internal seminar for knowledge transfer. (B) Number of trial participants involved in CTs at varying stages of recruitment (i.e., recruiting, active—not recruiting, or completed). Data was derived from clinicaltrials.gov on 03.02.2021 (dd.mm.yyyy). (C) Availability, accessibility, and content of CT guidelines that govern the conduct of CTs in the jurisdictions of the respective NMRAs of sponsored fellows at the long-term evaluation time-point.